Product Information
CLEOCIN 100 MG VAGINAL OVULE is a brand product labeled by Pharmacia & Upjohn Company LLC, priced at $60.1790 per EA under NDC 00009766705. Its NADAC has been published 135 times since Mar 6, 2024.
FDA first approved this application on Aug 13, 1999.
Strength
100 mg/1
Manufacturer
Pharmacia & Upjohn Company LLCNDC
00009766705
Classification
Brand
Dosage Form
SUPPOSITORY
Route
VAGINAL
Effective Date
9/23/2026
Active Ingredients
CLINDAMYCIN PHOSPHATEApproval Type
New Drug (NDA)
FDA Application
NDA050767FDA Approved
8/13/1999
On Market Since
8/13/1999
Pharmacological Classes
Price Statistics
The NADAC for CLEOCIN 100 MG VAGINAL OVULE has been published 135 times since Mar 6, 2024, and over the history we have for it it has risen 2.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $60.1790 per EA |
|---|---|
| All-time high | $60.2197 (Jun 10, 2026) |
| All-time low | $58.6323 (Apr 17, 2024) |
| 52-week high | $60.2197 |
| 52-week low | $58.6325 |
| Median price | $58.7772 |
| Average price | $59.1832 |
| Largest weekly change | +2.7% (Dec 31, 2025) |
| Weeks tracked | 135 |
| Tracking since | Mar 6, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the clindamycin phosphate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Pharmacia & Upjohn Company LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
clindamycin phosphate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Lincosamide Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CLEOCIN 100 MG VAGINAL OVULE?
The current National Average Drug Acquisition Cost (NADAC) for CLEOCIN 100 MG VAGINAL OVULE, manufactured by Pharmacia & Upjohn Company LLC, is $60.1790 per EA (NDC 00009766705), effective Sep 30, 2026.
How has the price of CLEOCIN 100 MG VAGINAL OVULE changed over time?
Over the history we have for it, the NADAC for CLEOCIN 100 MG VAGINAL OVULE has risen 2.1%. It has been tracked across 135 weekly CMS publications since Mar 6, 2024.
What are the highest and lowest recorded NADAC prices for CLEOCIN 100 MG VAGINAL OVULE?
Since Mar 6, 2024, the NADAC for CLEOCIN 100 MG VAGINAL OVULE has ranged from a low of $58.6323 (Apr 17, 2024) to a high of $60.2197 (Jun 10, 2026), with a median of $58.7772 per EA.
Are there cheaper alternatives to CLEOCIN 100 MG VAGINAL OVULE?
No other NADAC-published product currently shares the active ingredient and strength of CLEOCIN 100 MG VAGINAL OVULE in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures CLEOCIN 100 MG VAGINAL OVULE?
CLEOCIN 100 MG VAGINAL OVULE (NDC 00009766705) is labeled by Pharmacia & Upjohn Company LLC, and CMS classifies it as a brand product.